The results presented in Fig. 6a, b conclude that PLK1122/Sur20DC_TriVax immunisation was effective in completely eradicating clonally heterogeneous C1498-luc leukaemia in the majority of the mice when administered in combination with prolonged period of PD-L1 blockade (6 out of 10 mice survived). The gene discussed is CD274; the disease is leukemia.